ESC 2019 MITRA-FR at 2 Years: MitraClip Still No Better Than Med Therapy New data show no change in the overall primary end point, but a post hoc analysis leaves room for interpretation and further ...
In a recent commentary on Medscape, Dr John M. Mandrola strongly criticized that the new ESC guideline on the diagnosis and management of Chronic Coronary Syndromes dismissed ORBITA trial results. In ...
Results from a newly-released study heavily support the idea that Implantable cardioverter-defibrillator-use contributes to low mortality rates in patients suffering from heart failure. The ...
The updated guidelines were published in the European Heart Journal and were presented during the annual meeting of ESC in Paris, France, on the 2 nd September 2019. About Invokana®6 Invokana ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results